Oak Street Health, Inc. (NYSE:OSH – Get Rating) insider Geoffrey M. Price sold 53,366 shares of the business’s stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $30.01, for a total transaction of $1,601,513.66. Following the sale, the insider now directly owns 1,339,793 shares of the company’s stock, valued at $40,207,187.93. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Oak Street Health Stock Performance
OSH stock traded down $0.33 on Monday, hitting $29.96. The company’s stock had a trading volume of 1,538,652 shares, compared to its average volume of 2,549,680. The stock has a market cap of $7.22 billion, a price-to-earnings ratio of -13.62 and a beta of 3.04. The firm has a 50 day moving average of $21.54 and a two-hundred day moving average of $20.71. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 16.10. Oak Street Health, Inc. has a 1 year low of $13.29 and a 1 year high of $64.24.
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on the stock. Sanford C. Bernstein assumed coverage on shares of Oak Street Health in a research note on Thursday, May 26th. They set an “outperform” rating and a $26.00 target price for the company. Stifel Nicolaus lifted their price objective on Oak Street Health from $25.00 to $35.00 in a report on Wednesday, July 27th. Barclays lifted their price objective on Oak Street Health from $31.00 to $34.00 and gave the company an “overweight” rating in a report on Monday. Bank of America downgraded Oak Street Health from a “buy” rating to an “underperform” rating and decreased their price objective for the company from $26.00 to $18.00 in a report on Wednesday, June 15th. Finally, UBS Group lifted their price objective on Oak Street Health from $26.00 to $28.00 and gave the company a “neutral” rating in a report on Wednesday, August 3rd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $35.69.
Institutional Trading of Oak Street Health
Ad Investing Daily
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!
When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Hedge funds have recently added to or reduced their stakes in the stock. State of New Jersey Common Pension Fund D increased its position in Oak Street Health by 23.7% during the 4th quarter. State of New Jersey Common Pension Fund D now owns 77,309 shares of the company’s stock worth $2,562,000 after purchasing an additional 14,799 shares during the period. CWM LLC purchased a new stake in Oak Street Health in the 4th quarter valued at approximately $851,000. Toronto Dominion Bank boosted its stake in shares of Oak Street Health by 39.6% during the fourth quarter. Toronto Dominion Bank now owns 18,999 shares of the company’s stock valued at $629,000 after acquiring an additional 5,393 shares during the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its stake in shares of Oak Street Health by 32.4% during the 4th quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 27,078 shares of the company’s stock worth $934,000 after purchasing an additional 6,630 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System grew its stake in Oak Street Health by 57.0% in the 4th quarter. State Board of Administration of Florida Retirement System now owns 94,545 shares of the company’s stock worth $3,133,000 after acquiring an additional 34,335 shares during the period. 91.42% of the stock is owned by institutional investors and hedge funds.
About Oak Street Health
Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oak Street Health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Oak Street Health wasn’t on the list.
While Oak Street Health currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: marketbeat.com
